User Comments Wall

Display:
Load More Views
 
IIFL View

  • CARE Ratings

    CARE has triggers in place to grow in tandem with India’s credit growth story. The near term could be volatile due to ...

    Buy Reco. Price: 1,286.25

  • Ipca Labs.

    USFDA has barred entry of drugs manufactured at Ipca’s troubled facilities (Ratlam, Indore SEZ and Silvassa). Ipca expects ...

    Reduce Reco. Price: 744